MXPA01013273A - Compuestos amorfos y sus composiciones farmaceuticas. - Google Patents

Compuestos amorfos y sus composiciones farmaceuticas.

Info

Publication number
MXPA01013273A
MXPA01013273A MXPA01013273A MXPA01013273A MXPA01013273A MX PA01013273 A MXPA01013273 A MX PA01013273A MX PA01013273 A MXPA01013273 A MX PA01013273A MX PA01013273 A MXPA01013273 A MX PA01013273A MX PA01013273 A MXPA01013273 A MX PA01013273A
Authority
MX
Mexico
Prior art keywords
pharmaceutical compositions
nitric esters
amorphous
amorphous nitric
esters
Prior art date
Application number
MXPA01013273A
Other languages
English (en)
Inventor
Francesca Benedini
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox Sa filed Critical Nicox Sa
Publication of MXPA01013273A publication Critical patent/MXPA01013273A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C203/00Esters of nitric or nitrous acid
    • C07C203/02Esters of nitric acid
    • C07C203/04Esters of nitric acid having nitrate groups bound to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MXPA01013273A 1999-06-24 2000-06-21 Compuestos amorfos y sus composiciones farmaceuticas. MXPA01013273A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI001402A IT1312115B1 (it) 1999-06-24 1999-06-24 Composti amorfi e relative composizioni farmaceutiche
PCT/EP2000/005723 WO2001000563A1 (en) 1999-06-24 2000-06-21 Amorphous nitric esters and their pharmaceutical compositions

Publications (1)

Publication Number Publication Date
MXPA01013273A true MXPA01013273A (es) 2003-07-14

Family

ID=11383219

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01013273A MXPA01013273A (es) 1999-06-24 2000-06-21 Compuestos amorfos y sus composiciones farmaceuticas.

Country Status (23)

Country Link
US (1) US6753442B1 (es)
EP (1) EP1187803B1 (es)
JP (1) JP2003503380A (es)
KR (1) KR100672001B1 (es)
CN (1) CN1187312C (es)
AT (1) ATE302746T1 (es)
AU (1) AU781479B2 (es)
BR (1) BR0011831A (es)
CA (1) CA2377132A1 (es)
DE (1) DE60022188T2 (es)
DK (1) DK1187803T3 (es)
ES (1) ES2246878T3 (es)
HU (1) HUP0201721A3 (es)
IL (1) IL146789A0 (es)
IT (1) IT1312115B1 (es)
MX (1) MXPA01013273A (es)
NO (1) NO321523B1 (es)
NZ (1) NZ515757A (es)
PL (1) PL195557B1 (es)
RU (1) RU2248963C2 (es)
TR (1) TR200103624T2 (es)
WO (1) WO2001000563A1 (es)
ZA (1) ZA200109862B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1319202B1 (it) 2000-10-12 2003-09-26 Nicox Sa Farmaci per le malattie a base infiammatoria.
JP4092203B2 (ja) 2000-12-21 2008-05-28 ニトロメッド,インク. 新規のシクロオキシゲナーゼ2選択的阻害剤としての置換アリール化合物、組成物、および使用方法
EP1219306A1 (en) * 2000-12-29 2002-07-03 Nicox S.A. Compositions comprising cyclodextrins and NO- releasing drugs
AU2003248642A1 (en) 2002-06-11 2003-12-22 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
WO2004004648A2 (en) 2002-07-03 2004-01-15 Nitromed, Inc. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
EP1542972A4 (en) 2002-07-29 2008-01-23 Nitromed Inc CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITION AND METHOD OF USE
KR101157272B1 (ko) 2003-07-22 2012-06-15 아레나 파마슈티칼스, 인크. 5?ht2a 세로토닌 수용체의 조절자로서 이와 관련된질환의 예방 및 치료에 유용한 디아릴 및 아릴헤테로아릴우레아 유도체
TWI415845B (zh) 2006-10-03 2013-11-21 Arena Pharm Inc 用於治療與5-ht2a血清素受體相關聯病症之作為5-ht2a血清素受體之調節劑的吡唑衍生物
US9567327B2 (en) 2007-08-15 2017-02-14 Arena Pharmaceuticals, Inc. Imidazo[1,2-a]pyridine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
WO2009052246A1 (en) 2007-10-17 2009-04-23 Ovokaitys, Todd, F. Process for the modification of the solid state of a compound and co-amorphous compositions produced with same
US8377989B2 (en) * 2007-10-17 2013-02-19 Todd F. Ovokaitys Room temperature stable non-crystalline aspirin and method for the preparation thereof
ES2324007A1 (es) * 2007-10-25 2009-07-28 Ferrer Internacional, S.A. Una forma amorfa de un compuesto antiinflamatorio.
US20110021538A1 (en) 2008-04-02 2011-01-27 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
CN104784173B (zh) 2008-10-28 2019-07-26 艾尼纳制药公司 用于治疗5-ht2a5-羟色胺受体相关障碍的5-ht2a5-羟色胺受体调节剂组合物
US9126946B2 (en) 2008-10-28 2015-09-08 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
DK2344592T3 (en) 2008-11-04 2015-02-02 Dsm Ip Assets Bv D1413 HT radiation-curable optical fiber coatings
US10202598B2 (en) 2014-05-30 2019-02-12 Todd Frank Ovokaitys Methods and systems for generation, use, and delivery of activated stem cells
US10384985B2 (en) 2014-06-06 2019-08-20 B.K. Consultants, Inc. Methods and compositions for increasing the yield of, and beneficial chemical composition of, certain plants
US10040728B2 (en) 2014-06-06 2018-08-07 Todd Frank Ovokaitys Methods and compositions for increasing the bioactivity of nutrients
EP4119141A1 (en) 2015-06-12 2023-01-18 Axovant Sciences GmbH Nelotanserin for the prophylaxis and treatment of rem sleep behavior disorder
JP2018520187A (ja) 2015-07-15 2018-07-26 アクソヴァント サイエンシーズ ゲゼルシャフト ミット ベシュレンクテル ハフツングAxovant Sciences GmbH 神経変性疾患と関連する幻覚の予防および処置のために有用な5−ht2aセロトニン受容体のモジュレーターとしてのジアリールおよびアリールヘテロアリール尿素誘導体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1243367B (it) * 1990-07-26 1994-06-10 Italfarmaco Spa Derivati acidi benzoici sostituiti ad attivita' cardiovascolare
IT1256345B (it) 1992-08-20 1995-12-01 Esteri nitrici di derivati dell'acido 2-(2,6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione
IT1256450B (it) * 1992-11-26 1995-12-05 Soldato Piero Del Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
CA2190087C (en) * 1994-05-10 2005-08-02 Piero Del Soldato Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic activities
IT1276071B1 (it) * 1995-10-31 1997-10-24 Nicox Ltd Compositi ad attivita' anti-infiammatoria
KR19990001564A (ko) * 1997-06-16 1999-01-15 유충식 용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제
IT1307928B1 (it) 1999-01-26 2001-11-29 Nicox Sa Metodo di sintesi di nitrossimetilfenil esteri di derivatidell'aspirina.

Also Published As

Publication number Publication date
DK1187803T3 (da) 2005-11-28
TR200103624T2 (tr) 2002-04-22
HUP0201721A3 (en) 2003-08-28
ATE302746T1 (de) 2005-09-15
AU781479B2 (en) 2005-05-26
NO321523B1 (no) 2006-05-15
CA2377132A1 (en) 2001-01-04
DE60022188D1 (de) 2005-09-29
PL195557B1 (pl) 2007-10-31
ITMI991402A0 (it) 1999-06-24
ITMI991402A1 (it) 2000-12-24
US6753442B1 (en) 2004-06-22
RU2248963C2 (ru) 2005-03-27
BR0011831A (pt) 2002-03-19
IT1312115B1 (it) 2002-04-04
DE60022188T2 (de) 2006-06-08
WO2001000563A1 (en) 2001-01-04
CN1187312C (zh) 2005-02-02
NO20016232D0 (no) 2001-12-19
AU6264400A (en) 2001-01-31
ES2246878T3 (es) 2006-03-01
EP1187803B1 (en) 2005-08-24
ZA200109862B (en) 2003-05-28
EP1187803A1 (en) 2002-03-20
HUP0201721A2 (en) 2002-10-28
KR100672001B1 (ko) 2007-01-19
IL146789A0 (en) 2002-07-25
KR20020008220A (ko) 2002-01-29
JP2003503380A (ja) 2003-01-28
CN1356975A (zh) 2002-07-03
NZ515757A (en) 2004-02-27
NO20016232L (no) 2001-12-19
PL352529A1 (en) 2003-08-25

Similar Documents

Publication Publication Date Title
ZA200109862B (en) Amorphous nitric esters and their pharmaceutical compositions.
HUP0105113A3 (en) Benzoheterocycles and their use as mek inhibitors and pharmaceutical compositions containing the compounds
IL150223A0 (en) Lipopeptides and pharmaceutical compositions containing the same
TW200510368A (en) Pharmaceutical compositions and combinations of novel non-imidazole compounds
HUP0302412A3 (en) Betha-carboline derivatives useful as inhibitors of phosphodiesterase and pharmaceutical compositions containing the same
HUP0302922A3 (en) Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation and pharmaceutical compositions containing them
HUP0201011A2 (en) Aminopyrimidines as sorbitol dehydrogenase inhibitors and pharmaceutical compositions containing them
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
SI1353919T1 (sl) Novi derivati kinuklidina in medicinske zmesi, kijih vsebujejo.
IL151372A0 (en) Cyclopropyl-fused pyrrolidine derivatives and pharmaceutical compositions containing the same
HK1061037A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
HUP0204071A3 (en) Nitrogenous cyclic compounds and pharmaceutical compositions containing the same and their use
IL152718A0 (en) Piperidine derivatives and pharmaceutical compositions containing the same
IL152451A0 (en) 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same
HUP0301472A3 (en) Carbamate caspase inhibitors and uses thereof and pharmaceutical compositions containing them
IL153123A0 (en) N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same
HK1053107A1 (zh) 作為jnk抗化劑的pyrazoloanthrone及其衍生物和它們的成份
DK1246625T3 (da) Anvendelser og sammensætninger af nitratestere til tilvejebringelse af sedering
EP1311477A4 (en) NEW THIOCARBAMIDIC ACID DERIVATIVES AND MEDICAMENTS CONTAINING THEM
HUP0103382A3 (en) Naaladase inhibitors useful as pharmaceutical compounds and compositions
IL162325A0 (en) Hiv integrase inhibitor compounds and pharmaceutical compositions containing the same
AP2003002716A0 (en) Medicinal compositions containing propenone derivatives.
HUP0400654A3 (en) Substituted 8-arylquinoline phosphodiesterase 4 inhibitors and pharmaceutical compositions containing them
HUP0203787A3 (en) Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent, pharmaceutical compositions containing them and their use

Legal Events

Date Code Title Description
FG Grant or registration